Antithrombin (recombinant) Pregnancy and Breastfeeding Warnings
Brand names: ATryn
Antithrombin (recombinant) Pregnancy Warnings
Antithrombin recombinant has been assigned to pregnancy category C by the FDA. Animal studies have failed to reveal evidence of embryofetotoxicity. There are no controlled data in human pregnancy. Antithrombin recombinant is only recommended for use during pregnancy when benefit outweighs risk.
Antithrombin (recombinant) Breastfeeding Warnings
There are no data on the excretion of antithrombin recombinant into human milk. The manufacturer recommends that caution be used when administering antithrombin recombinant to nursing women.
See also
References for pregnancy information
- (2009) "Product Information. ATryn (antithrombin recombinant)." Ovation Pharmaceuticals Inc
References for breastfeeding information
- (2009) "Product Information. ATryn (antithrombin recombinant)." Ovation Pharmaceuticals Inc
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.